Drug Type Small molecule drug |
Synonyms Levanex, Levcromakalim, Levro-cromakalim + [3] |
Target |
Mechanism KATP channels activators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18N2O3 |
InChIKeyTVZCRIROJQEVOT-CABCVRRESA-N |
CAS Registry94535-50-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arrhythmias, Cardiac | NDA/BLA | - | - | |
Arrhythmias, Cardiac | NDA/BLA | - | - | |
Asthma | NDA/BLA | - | - | |
Asthma | NDA/BLA | - | - | |
Hypertension | NDA/BLA | - | - | |
Hypertension | NDA/BLA | - | - | |
Myocardial Ischemia | NDA/BLA | - | - | |
Myocardial Ischemia | NDA/BLA | - | - |
Not Applicable | 8 | qoxwrrwhqs(eguxtdkikd) = myhzbmxciz phdtqauspt (ikomkmpgvl ) | Negative | 01 Aug 2024 | |||
Placebo | qoxwrrwhqs(eguxtdkikd) = rrruaivzye phdtqauspt (ikomkmpgvl ) | ||||||
Not Applicable | 27 | ltxcppnwrp(mnnxtosqjf) = odguqfpolc fpidnpzkxd (ngwfbyivhe ) | Positive | 01 Mar 2024 | |||
NCT04012047 (Pubmed) Manual | Not Applicable | 17 | bhvyxnstuo(pglfmobdtj) = cbhcxjfofm mtlksunltp (jtugpvwbwh ) View more | - | 04 Sep 2021 | ||
Placebo | bhvyxnstuo(pglfmobdtj) = zdoemxoanb mtlksunltp (jtugpvwbwh ) View more | ||||||
Not Applicable | 16 | (ngkqgcdblr) = kdiaxkszvi zaraywszzb (xorinwdnut ) View more | Positive | 01 Sep 2019 | |||
placebo | (ngkqgcdblr) = roaphviowa zaraywszzb (xorinwdnut ) View more |